Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Chinese Medicine
Published in: Chinese Medicine 1/2014

Open Access 01-12-2014 | Research

Popularity and customer preferences for over-the-counter Chinese medicines perceived by community pharmacists in Shanghai and Guangzhou: a questionnaire survey study

Authors: Shuai Ge, Tian-Tian He, Hao Hu

Published in: Chinese Medicine | Issue 1/2014

Login to get access

Abstract

Background

This study interviewed community pharmacists in Shanghai and Guangzhou for their perception of the popular categories of over-the-counter (OTC) Chinese medicines and the factors affecting customer preferences for OTC Chinese medicines.

Methods

A cross-sectional survey was carried out in six main administrative districts in Guangzhou and eight main administrative districts in Shanghai, China. Descriptive statistical analysis was conducted in this study.

Results

OTC Chinese medicines contributed 21–50% among all the pharmaceutical sales by the community pharmacies. The prevalent categories of OTC Chinese medicines were common cold medicines, respiratory system medicines, digestive system agents, gynecological medicines, health tonic medicines, and qing re (heat-clearing) and qu du (detoxifying) medicines. Customers were more concerned about medical factors of OTC Chinese medicines than business factors. Among the medical factors, the most important was drug safety, followed by efficacy, contraindications, indications, and side effects. Among the business factors, the most important were brand and price.

Conclusions

This study identified the top sales categories of OTC Chinese medicines in Shanghai and Guangzhou and the important factors such as drug safety, efficacy, period of validity, contraindications, and indications that are affecting the customer preferences for OTC Chinese medicines.
Appendix
Available only for authorised users
Literature
1.
Pandya RN, Jhaveri KS, Vyas FI, Patel VJ: Prevalence, pattern and perceptions of self-medication in medical students. Int J Basic Clin Pharmacol. 2013, 2 (3): 275-280.CrossRef
2.
You JH, Wong FY, Chan FW, Wong EL, Yeoh EK: Public perception on the role of community pharmacists in self-medication and self-care in Hong Kong. BMC Clin Pharmacol. 2011, 11 (1): 19-PubMedCentralCrossRefPubMed
3.
Baeten S, Van Ourti T, Van Doorslaer E: Rising inequalities in income and health in China: who is left behind?. J Health Econ. 2013, 32 (6): 1214-1229.CrossRefPubMed
4.
5.
Bower AB, Grau SL, Taylor VA: Over-the-counter vs. prescription medications: are consumer perceptions of the consequences of drug instruction non-compliance different?. Int J Consum Res. 2012, 37 (2): 229-233.
6.
Chung CH, Lau CH, Chan WK, You HS, Wong LY, Griffiths SM: Use of Chinese and western over-the-counter medications in Hong Kong. Chin Med. 2010, 5: 41-CrossRef
7.
Ryan M, Yule B: Switching drugs from prescription-only to over-the-counter availability: economic benefits in the United Kingdom. Health Policy. 1990, 16 (3): 233-239.CrossRefPubMed
8.
Lynch N, Berry D: Differences in perceived risks and benefits of herbal, over-the-counter conventional, and prescribed conventional, medicines, and the implications of this for the safe and effective use of herbal products. Complement Ther Med. 2007, 15: 84-91.CrossRefPubMed
9.
10.
Feng Y, Wu Z, Zhou X, Zhou Z, Fan W: Knowledge discovery in traditional Chinese medicine: state of the art and perspectives. Artif Intell Med. 2006, 38 (3): 219-236.CrossRefPubMed
11.
Harmsworth K, Lewith GT: Attitudes to traditional Chinese medicine amongst Western trained doctors in the People’s Republic of China. Soc Sci Med. 2001, 52 (1): 149-153.CrossRefPubMed
12.
Furnham A, Vincent C, Wood R: The health beliefs and behaviors of three groups of complementary medicine and a general practice group of patients. J Altern Complement Med. 1995, 1 (4): 347-359.CrossRefPubMed
13.
Chan MF, Mok E, Wong YS, Tong TF, Day MC, Tang CKY, Wong DHC: Attitudes of Hong Kong Chinese to traditional Chinese medicine and western medicine: survey and cluster analysis. Complement Ther Med. 2003, 11 (2): 103-109.CrossRefPubMed
14.
Shahrokh LE, Lukaszuk JM, Prawitz AD: Elderly herbal supplement users less satisfied with medical care than nonusers. J Am Diet Assoc. 2005, 105 (7): 1138-1140.CrossRefPubMed
15.
Yu WZ: The marketing innovation of the self-medication OTC drugs with reference to the reform of medical treatment. The Proceedings of 2009 International Conference on Information Management, Innovation Management and Industrial Engineering, 26-27 December, 2009, Xi'an. 2009, IEEE: IEEE, 81-87.
16.
Chan K: Some aspects of toxic contaminants in herbal medicines. Chemosphere. 2003, 52 (9): 1361-1371.CrossRefPubMed
17.
18.
19.
Wenzel RG, Sarvis CA, Krause ML: Over-the-counter drugs for acute migraine attacks: literature review and recommendations. Pharmacotherapy. 2003, 23: 494-505.CrossRefPubMed
20.
Chung VC, Ma PH, Lau CH, Wong SY, Yeoh EK, Griffiths SM: Views on traditional Chinese medicine amongst Chinese population: a systematic review of qualitative and quantitative studies. Health Expect. 2012, May 31. doi:10.1111/j.1369-7625.2012.00794.x. [Epub ahead of print]
21.
Hon EK, Lee K, Tse HM, Lam LN, Tam KC, Chu KM, Lee V, Lau C, Leung TF: A survey of attitudes to traditional Chinese medicine in Hong Kong pharmacy students. Complement Ther Med. 2004, 12 (1): 51-56.CrossRefPubMed
22.
Chung VC, Ma PH, Tang TS, Lau CH, Kim JH, Griffiths SM: Do patients tell their clinicians they are using both prescribed and over the counter allopathic and traditional medicines?. Eur J Integr Med. 2011, 3 (4): 289-298.CrossRef
23.
Li X, Yang G, Li X, Zhang Y, Yang J, Chang J, Sun X, Zhou X, Guo Y, Xu Y, Liu J, Bensoussan A: Traditional Chinese medicine in cancer care: a review of controlled clinical studies published in Chinese. PLoS One. 2013, 8 (4): e60338-PubMedCentralCrossRefPubMed
24.
Liao YH, Lin CC, Li TC, Lin JG: Utilization pattern of traditional Chinese medicine for liver cancer patients in Taiwan. BMC Complement Altern Med. 2013, 12: 146-CrossRef
25.
Li GD, Wu XF: Feasibility and design about OTC pharmacies in hospitals. Guo Ji Yi Yao Wei Sheng Dao Bao. 2004, 10 (8): 143-145.
26.
Company MDC: Market research of clinical medication in hospitals of traditional Chinese medicine in 2004. 2004, Beijing: MDC Company
27.
Smith F: The extended role of the community pharmacist: implications for the primary health care team. J Soc Admin Pharm. 1990, 7: 101-110.
28.
Chan TYK, Lee KKC, Critchley JAJH: The needs and sources of drug information among pharmacists in Hong Kong. J Clin Pharm Ther. 1996, 21 (5): 325-330.CrossRefPubMed
29.
Fang Y, Yang S, Zhou S, Jiang M, Liu J: Community pharmacy practice in China: past, present and future. Int J Clin Pharm. 2013, 35 (4): 520-528.CrossRefPubMed
30.
31.
32.
33.
Chen XQ: Main lists of time-honored Chinese medicine companies in business after the Liberation. Zhongguo Yao Xue Za Zhi. 1999, 34 (9): 632-
34.
Cialdini RB: Influence. 2009, New York: HarperCollins e-books: New York Press
35.
Deval H, Mantel SP, Kardes FR, Posavac SS: How naïve theories drive opposing inferences from the same information. J Consum Res. 2013, 39: 1185-1201.CrossRef
36.
Guan X, Liang H, Xue Y, Shi L: An analysis of China’s national essential medicines policy. J Public Health Policy. 2011, 32 (3): 305-319.CrossRefPubMed
37.
Baruch Y: Response rates in academic studies-a comparative analysis. Hum Relat. 1999, 52: 421-434.
38.
Cao JJ: Study on pharmacodynamics of Xiao-chai-hu tablets. Zhongguo Lin Chuang Yao Li Xue Za Zhi. 2010, 26 (2): 88-89.
39.
40.
Li BM: The developing trend of the OTC market and research of the main popular OTC brand products in China. Heilongjiang Yi Xue Za Zhi. 2014, in press
41.
42.
Kim JH, Kwong EM, Chung VC, Lee JC, Wong T, Goggins WB: Acute adverse events from over-the-counter Chinese herbal medicines: a population-based survey of Hong Kong Chinese. BMC Complement Altern Med. 2013, 13: 336-PubMedCentralCrossRefPubMed
43.
44.
Luo H, Li Q, Flower A, Lewith G, Liu JP: Comparison of effectiveness and safety between granules and decoction of Chinese herbal medicine: a systematic review of randomized clinical trials. J Ethnopharmacol. 2012, 140 (3): 555-567.CrossRefPubMed
45.
Jha V, Rathi M: Natural medicines causing acute kidney injury. Semin Nephrol. 2008, 28 (4): 416-428.CrossRefPubMed
46.
Kelvin C: An overview on safety issues of interactions between traditional herbal medicines and pharmaceutical medicines. Boletín Latinoamericano y del Caribe de Plantas Medicinales y Aromáticas. 2008, 7 (6): 312-331.
47.
Raynor DK, Dickinson R, Knapp P, Long AF, Nicolson DJ: Buyer beware? Does the information provided with herbal products available over the counter enable safe use?. BMC Med. 2011, 9: 94-PubMedCentralCrossRefPubMed
48.
Hughes L, Whittlesea C, Luscombe D: Patients’ knowledge and perceptions of the side-effects of OTC medication. J Clin Pharm Ther. 2002, 27 (4): 243-248.CrossRefPubMed
49.
Tachjian A, Maria V, Jahangir A: Use of herbal products and potential interactions in patients with cardiovascular diseases. J Am Coll Cardiol. 2010, 55 (6): 515-525.PubMedCentralCrossRefPubMed
50.
Gratus C, Wilson S, Greenfield SM, Damery SL, Warmington SA, Grieve R, Steven NM, Routledge P: The use of herbal medicines by people with cancer. BMC Complement Altern Med. 2009, 9: 14-PubMedCentralCrossRefPubMed
51.
Xu Q, Bauer R, Hendry BM, Fan TP, Zhao Z, Duez P, Simmonds MS, Witt CM, Lu A, Robinson N, Guo DA, Hylands PJ: The quest for modernisation of traditional Chinese medicine. BMC Complement Altern Med. 2013, 13: 132-PubMedCentralCrossRefPubMed
52.
Mhatre SSS: Over-the-counter medication use and its impact on quality of life of the elderly. Value Health. 2012, 15: A203-CrossRef
53.
Song PP, Gao JJ, Kokudo N, Tang W: Standardization of traditional Chinese medicine and evaluation of evidence from its clinical practice. Drug Discov Ther. 2011, 5 (6): 261-265.CrossRefPubMed
54.
Shang HC, Li YP, Chen J, Zhang JH, Zhang BL: New trends for clinical research of traditional Chinese medicine in China. Chin Med J (Engl). 2008, 121 (11): 1050-1051.
55.
56.
Fan TP, Deal G, Koo HL, Rees D, Sun H, Chen S, Dou JH, Makarov VG, Pozharitskaya ON, Shikov AN, Kim YS, Huang YT, Chang YS, Jia W, Dias A, Wong VC, Chan K: Future development of global regulations of Chinese herbal products. J Ethnopharmacol. 2012, 140 (3): 568-586.CrossRefPubMed
57.
Liu GG, Zhao Z, Cai R, Yamada T: Equity in health care access to: assessing the urban health insurance reform in China. Soc Sci Med. 2002, 55 (10): 1779-1794.CrossRefPubMed
58.
Chung VC, Ma PH, Wang HH, Wang JJ, Hong LC, Wei X, Wong SY, Tang JL, Griffiths SM: Integrating traditional Chinese medicine services in community health centers: insights into utilization patterns in the Pearl River Region of China. Evid Based Complement Alternat Med. 2013, 426360-
59.
Cai Y, Mao Z, Xu B, Wu B:Factors associated with traditional Chinese medicine utilization among urban community health centers in Hubei Province of China.Asia-Pacific. J Public Health. 2013, published online before print, doi:10.1177/1010539513491415,
60.
Cho JH, Lee TJ: The factors contributing to expenditures on over-the-counter drugs in South Korea. Value in Health Regional Issues. 2013, 2 (1): 147-151.CrossRef
Metadata
Title
Popularity and customer preferences for over-the-counter Chinese medicines perceived by community pharmacists in Shanghai and Guangzhou: a questionnaire survey study
Authors
Shuai Ge
Tian-Tian He
Hao Hu
Publication date
01-12-2014
Publisher
BioMed Central
Published in
Chinese Medicine / Issue 1/2014
Electronic ISSN: 1749-8546
DOI
https://doi.org/10.1186/1749-8546-9-22

Other articles of this Issue 1/2014

Chinese Medicine 1/2014 Go to the issue

Research

Determination of production regions for pollution-free Chinese medicinal materials by geographic information system: Achyranthes bidentata (Niu Qi) in Tianjin as an example

Research

Panax ginseng therapy for chronic obstructive pulmonary disease: a clinical trial protocol and pilot study

Research

Amygdalin isolated from Semen Persicae (Tao Ren) extracts induces the expression of follistatin in HepG2 and C2C12 cell lines

Research

Differential effects of selective frankincense (Ru Xiang) essential oil versus non-selective sandalwood (Tan Xiang) essential oil on cultured bladder cancer cells: a microarray and bioinformatics study

Research

Anti-infective and cytotoxic properties of Bupleurum marginatum

Research

Isodeoxyelephantopin from Elephantopus scaber (Didancao) induces cell cycle arrest and caspase-3-mediated apoptosis in breast carcinoma T47D cells and lung carcinoma A549 cells